{"database": "lobbying", "table": "lobbying_activities", "rows": [[1546583, "0354785d-fe5d-46b7-8a16-220ad90c3912", "Q2", "RED+BLUE STRATEGIES", 400693064, "EXPRESS SCRIPTS INC.", 2014, "second_quarter", "PHA", "H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy\n\nRules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.Issues impacting PBMs in up coming health related legislation.\n\nPolicies related to stopping the diversion of prescription medications in the nation's drug supply chain.\n\nChanges in International Naming policies for generic medications.\n\nACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits.\n\nIssues regarding prescription drug coverage for DoD\n\nIssues related to Part D coverage for Medicare Beneficiaries in Hospice Care.", "Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2014-07-07T16:20:17.773000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1546583"], "units": {}, "query_ms": 17.911890987306833, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}